RECRUITING

Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)

Conditions

Fibroid Leiomyoma Senescent cells Fibroids Leiomyomas

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators are evaluating the role of senescent cells in uterine fibroids.

Official Title

Role of Senescent Cells in Uterine Fibroid Pathogenesis

Quick Facts

Study Start:2023-11-01

Study Completion:2027-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06135870

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 55 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT

Inclusion Criteria	Exclusion Criteria
* Subjects must be women above the age of ≥18 - ≤55 years. * Women with suspected uterine fibroids. * Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum. * Subject must be able to understand, read and speak English or Spanish and subsequently, be able to understand what she is consenting to in terms of procedures and use/disclosure of protected health information.	* Unwilling to sign the consent form or complete questionnaire. * Pregnancy. * Cancer of the uterus

Inclusion Criteria

Exclusion Criteria

* Subjects must be women above the age of ≥18 - ≤55 years.
* Women with suspected uterine fibroids.
* Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum.
* Subject must be able to understand, read and speak English or Spanish and subsequently, be able to understand what she is consenting to in terms of procedures and use/disclosure of protected health information.

* Unwilling to sign the consent form or complete questionnaire.
* Pregnancy.
* Cancer of the uterus

Contacts and Locations

Study Contact

James Segars, MD

CONTACT

410-614-2000

jsegars2@jhmi.edu

Bhuchitra Singh, MD, MPH, MBA

CONTACT

410-614-2000

bsingh10@jhmi.edu

Principal Investigator

James Segars, MD

PRINCIPAL_INVESTIGATOR

Johns Hopkins University

Study Locations (Sites)

Johns Hopkins Hospital

Baltimore, Maryland, 21287

United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

James Segars, MD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-01

Study Completion Date2027-12-31

Study Record Updates

Study Start Date2023-11-01

Study Completion Date2027-12-31

Terms related to this study

Keywords Provided by Researchers

Senescent cells
Fibroids
Leiomyomas

Additional Relevant MeSH Terms

Fibroid
Leiomyoma